HAPKIDI
Live / Registered — Registered (as of 14 Jul 2026)
What this means for you
Registered since 14 Jul 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Jul 2032: the §71 affidavit of use).
Record
- Serial number
- 79424971
- Registration number
- 8340006
- Mark type
- Word mark
- Filed
- 22 Apr 2025
- Published for opposition
- 26 May 2026
- Registered
- 14 Jul 2026
- Next maintenance filing
- §71 affidavit of use, due by 14 Jul 2032 (grace period to 14 Jan 2033)
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders, pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood, pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations
Owner
Prosecution history
- 14 Oct 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 15 Sept 2026 — TEAS SECTION 7 REQUEST RECEIVED
- 14 Jul 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Jul 2026 — REGISTERED-PRINCIPAL REGISTER
- 26 May 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 May 2026 — PUBLISHED FOR OPPOSITION
- 20 May 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Apr 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Apr 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Dec 2025 — REFUSAL PROCESSED BY IB
- 12 Nov 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 12 Nov 2025 — REFUSAL PROCESSED BY MPU
- 26 Sept 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW